Related Experiment Video

Updated: Jan 22, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

13.2K

Massive hepatic necrosis-associated acute liver failure

Tao Lin1, Chenhao Tong1,2, Roman Liebe3

  • 1Department of Medicine II, Section Molecular Hepatology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Egastroenterology
|January 21, 2026
PubMed

Insights

Massive hepatic necrosis (MHN) causes severe acute liver failure (ALF) with high mortality. Liver regeneration in MHN-associated ALF relies on liver progenitor cells (LPCs), crucial for patient outcomes.

Area of Science:

  • Hepatology
  • Pathology
  • Regenerative Medicine

Background:

  • Massive hepatic necrosis (MHN) is the most severe liver lesion in acute liver failure (ALF).
  • MHN-associated ALF has a higher mortality rate compared to other ALF causes.
  • Viral hepatitis (A, B, E), autoimmune hepatitis, and drug toxicity are common MHN-associated ALF triggers.

Purpose of the Study:

  • To review the pathophysiology of MHN-associated ALF.
  • To discuss recent advances in liver progenitor cell (LPC) biology.
  • To highlight the role of LPCs in liver regeneration and clinical outcomes in MHN-associated ALF.

Main Methods:

  • Literature review of pathophysiology and LPC biology.
  • Analysis of clinical outcomes in MHN-associated ALF.
  • Synthesis of current research on liver regeneration mechanisms.

Main Results:

  • MHN-associated ALF is characterized by extensive hepatocyte loss.
  • Liver regeneration in MHN-associated ALF is dependent on liver progenitor cells (LPCs).
  • LPCs are critical for determining patient outcomes in severe acute liver injury.

Conclusions:

  • Understanding MHN-associated ALF pathophysiology is vital for improving patient survival.
  • LPC biology offers potential therapeutic targets for enhancing liver regeneration.
  • Further research into LPCs is essential for managing severe acute liver failure.
Keywords:
Acute Liver FailureCellular MicroenvironmentLiver DiseasesLiver RegenerationMassive Hepatic Necrosis

More Related Videos

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

22.5K
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.0K

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
901
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
476
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
811
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
526
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.4K